Pulmatrix, Inc. (PULM)

SpringWorks Therapeutics Statistics

Total Valuation

Pulmatrix has a market cap or net worth of $19.80 million. The enterprise value is $12.05 million.

Market Cap	19.80M
Enterprise Value	12.05M

Important Dates

The next estimated earnings date is Tuesday, August 12, 2025, before market open.

Earnings Date	Aug 12, 2025
Ex-Dividend Date	n/a

Share Statistics

Pulmatrix has 3.65 million shares outstanding.

Current Share Class	3.65M
Shares Outstanding	3.65M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.66%
Owned by Institutions (%)	8.62%
Float	3.63M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	10.29
Forward PS	n/a
PB Ratio	2.76
P/TBV Ratio	2.76
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	6.27
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 8.90

Current Ratio	8.90
Quick Ratio	8.55
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -93.19% and return on invested capital (ROIC) is -35.01%.

Return on Equity (ROE)	-93.19%
Return on Assets (ROA)	-31.67%
Return on Invested Capital (ROIC)	-35.01%
Return on Capital Employed (ROCE)	-136.25%
Revenue Per Employee	$960,500
Profits Per Employee	-$6.10M
Employee Count	2
Asset Turnover	0.10
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +133.19% in the last 52 weeks. The beta is 1.45, so Pulmatrix's price volatility has been higher than the market average.

Beta (5Y)	1.45
52-Week Price Change	+133.19%
50-Day Moving Average	7.04
200-Day Moving Average	6.28
Relative Strength Index (RSI)	35.58
Average Volume (20 Days)	9,189

Short Selling Information

The latest short interest is 25,383, so 0.69% of the outstanding shares have been sold short.

Short Interest	25,383
Short Previous Month	16,754
Short % of Shares Out	0.69%
Short % of Float	0.70%
Short Ratio (days to cover)	0.44

Income Statement

In the last 12 months, Pulmatrix had revenue of $1.92 million and -$12.19 million in losses. Loss per share was -$3.34.

Revenue	1.92M
Gross Profit	1.89M
Operating Income	-9.74M
Pretax Income	-8.85M
Net Income	-12.19M
EBITDA	-9.67M
EBIT	-9.74M
Loss Per Share	-$3.34

Balance Sheet

The company has $7.71 million in cash and n/a in debt, giving a net cash position of $7.71 million or $2.11 per share.

Cash & Cash Equivalents	7.71M
Total Debt	n/a
Net Cash	7.71M
Net Cash Per Share	$2.11
Equity (Book Value)	7.15M
Book Value Per Share	1.96
Working Capital	7.14M

Cash Flow

In the last 12 months, operating cash flow was -$9.81 million and capital expenditures -$244,000, giving a free cash flow of -$10.05 million.

Operating Cash Flow	-9.81M
Capital Expenditures	-244,000
Free Cash Flow	-10.05M
FCF Per Share	-$2.75

Margins

Gross Margin	98.28%
Operating Margin	-506.98%
Pretax Margin	-634.67%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Pulmatrix does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-61.70%
FCF Yield	-50.88%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on March 1, 2022. It was a reverse split with a ratio of 1:20.

Last Split Date	Mar 1, 2022
Split Type	Reverse
Split Ratio	1:20

Scores

Pulmatrix has an Altman Z-Score of -45.4 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-45.4
Piotroski F-Score	2